Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
Clinical trial NCT04428424 · COMPLETED
Trial details
- NCT number
- NCT04428424
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-05
- Primary completion
- 2020-08-30
- Enrollment
- 1493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.